These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 25372628)

  • 1. De novo synthesis and biological evaluation of C6″-substituted C4″-amide analogues of SL0101.
    Mrozowski RM; Sandusky ZM; Vemula R; Wu B; Zhang Q; Lannigan DA; O'Doherty GA
    Org Lett; 2014 Nov; 16(22):5996-9. PubMed ID: 25372628
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regioselective Synthesis of a
    Li Y; Sandusky ZM; Vemula R; Zhang Q; Wu B; Fukuda S; Li M; Lannigan DA; O'Doherty GA
    Org Lett; 2020 Feb; 22(4):1448-1452. PubMed ID: 32009414
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis of a potent and selective inhibitor of p90 Rsk.
    Maloney DJ; Hecht SM
    Org Lett; 2005 Mar; 7(6):1097-9. PubMed ID: 15760148
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analogs of the RSK inhibitor SL0101: optimization of in vitro biological stability.
    Hilinski MK; Mrozowski RM; Clark DE; Lannigan DA
    Bioorg Med Chem Lett; 2012 May; 22(9):3244-7. PubMed ID: 22464132
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of rhamnose substituents on the potency of SL0101, an inhibitor of the Ser/Thr kinase, RSK.
    Smith JA; Maloney DJ; Clark DE; Xu Y; Hecht SM; Lannigan DA
    Bioorg Med Chem; 2006 Sep; 14(17):6034-42. PubMed ID: 16723233
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural basis for the activity of the RSK-specific inhibitor, SL0101.
    Smith JA; Maloney DJ; Hecht SM; Lannigan DA
    Bioorg Med Chem; 2007 Jul; 15(14):5018-34. PubMed ID: 17512736
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Two widely used RSK inhibitors, BI-D1870 and SL0101, alter mTORC1 signaling in a RSK-independent manner.
    Roffé M; Lupinacci FC; Soares LC; Hajj GN; Martins VR
    Cell Signal; 2015 Aug; 27(8):1630-42. PubMed ID: 25889895
    [TBL] [Abstract][Full Text] [Related]  

  • 8. De novo asymmetric syntheses of SL0101 and its analogues via a palladium-catalyzed glycosylation.
    Shan M; O'Doherty GA
    Org Lett; 2006 Oct; 8(22):5149-52. PubMed ID: 17048865
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of the first specific inhibitor of p90 ribosomal S6 kinase (RSK) reveals an unexpected role for RSK in cancer cell proliferation.
    Smith JA; Poteet-Smith CE; Xu Y; Errington TM; Hecht SM; Lannigan DA
    Cancer Res; 2005 Feb; 65(3):1027-34. PubMed ID: 15705904
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identifying requirements for RSK2 specific inhibitors.
    Wright EB; Fukuda S; Li M; Li Y; O'Doherty GA; Lannigan DA
    J Enzyme Inhib Med Chem; 2021 Dec; 36(1):1798-1809. PubMed ID: 34348556
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insights into the inhibition of the p90 ribosomal S6 kinase (RSK) by the flavonol glycoside SL0101 from the 1.5 Å crystal structure of the N-terminal domain of RSK2 with bound inhibitor.
    Utepbergenov D; Derewenda U; Olekhnovich N; Szukalska G; Banerjee B; Hilinski MK; Lannigan DA; Stukenberg PT; Derewenda ZS
    Biochemistry; 2012 Aug; 51(33):6499-510. PubMed ID: 22846040
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis of SL0101 carbasugar analogues: carbasugars via Pd-catalyzed cyclitolization and post-cyclitolization transformations.
    Shan M; O'Doherty GA
    Org Lett; 2010 Jul; 12(13):2986-9. PubMed ID: 20518547
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Divergent off-target effects of RSK N-terminal and C-terminal kinase inhibitors in cardiac myocytes.
    Stathopoulou K; Schobesberger S; Bork NI; Sprenger JU; Perera RK; Sotoud H; Geertz B; David JP; Christ T; Nikolaev VO; Cuello F
    Cell Signal; 2019 Nov; 63():109362. PubMed ID: 31344438
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Y-box binding protein-1 serine 102 is a downstream target of p90 ribosomal S6 kinase in basal-like breast cancer cells.
    Stratford AL; Fry CJ; Desilets C; Davies AH; Cho YY; Li Y; Dong Z; Berquin IM; Roux PP; Dunn SE
    Breast Cancer Res; 2008; 10(6):R99. PubMed ID: 19036157
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The p90 ribosomal S6 kinase (RSK) inhibitor BI-D1870 prevents gamma irradiation-induced apoptosis and mediates senescence via RSK- and p53-independent accumulation of p21WAF1/CIP1.
    Neise D; Sohn D; Stefanski A; Goto H; Inagaki M; Wesselborg S; Budach W; Stühler K; Jänicke RU
    Cell Death Dis; 2013 Oct; 4(10):e859. PubMed ID: 24136223
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of RSK/YB-1 signaling enhances the anti-cancer effect of enzalutamide in prostate cancer.
    Shiota M; Yokomizo A; Takeuchi A; Itsumi M; Imada K; Kashiwagi E; Inokuchi J; Tatsugami K; Uchiumi T; Naito S
    Prostate; 2014 Jun; 74(9):959-69. PubMed ID: 24740858
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and Structure-Activity Relationship Study of 5a-Carbasugar Analogues of SL0101.
    Li M; Li Y; Mrozowski RM; Sandusky ZM; Shan M; Song X; Wu B; Zhang Q; Lannigan DA; O'Doherty GA
    ACS Med Chem Lett; 2015 Jan; 6(1):95-9. PubMed ID: 25589938
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of a RSK Inhibitor as a Novel Therapy for Triple-Negative Breast Cancer.
    Ludwik KA; Campbell JP; Li M; Li Y; Sandusky ZM; Pasic L; Sowder ME; Brenin DR; Pietenpol JA; O'Doherty GA; Lannigan DA
    Mol Cancer Ther; 2016 Nov; 15(11):2598-2608. PubMed ID: 27528706
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stereoselective Synthesis and Evaluation of C6″-Substituted 5a-Carbasugar Analogues of SL0101 as Inhibitors of RSK1/2.
    Li M; Li Y; Ludwik KA; Sandusky ZM; Lannigan DA; O'Doherty GA
    Org Lett; 2017 May; 19(9):2410-2413. PubMed ID: 28441024
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Homology model of RSK2 N-terminal kinase domain, structure-based identification of novel RSK2 inhibitors, and preliminary common pharmacophore.
    Nguyen TL; Gussio R; Smith JA; Lannigan DA; Hecht SM; Scudiero DA; Shoemaker RH; Zaharevitz DW
    Bioorg Med Chem; 2006 Sep; 14(17):6097-105. PubMed ID: 16723234
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.